Tricuspid / Pulmonary valve

Register for free to this webinar on Thursday 3 September at 5:00pm with M. Adamo, M. Sitges, G. Rosano and M. Wild and learn to recognize the signs and symptoms related with tricuspid regurgitation, and much more!

Watch these recordings from EuroPCR 2026 and PCR London Valves 2025 on tricuspid valve.

P. Nikolai, P. Mitkowski and M. Weber share how to identify lead‑induced tricuspid regurgitation and optimise lead management for T‑TEER and TTVR.

An 80-year-old woman was referred for persistent right heart failure despite previous surgical mitral repair and subsequent transcatheter tricuspid intervention. Over time, she developed progressive symptoms with recurrent severe tricuspid regurgitation, refractory to optimised medical therapy.

Multimodality imaging confirmed significant right-sided chamber dilatation and complex valve anatomy,...

This session addresses the complexities of treating tricuspid regurgitation, offering insights into tailored treatment options and complication management. Through detailed case studies from China and Germany, it highlights practical approaches and bailout strategies for tricuspid valve interventions.

This session examines right-sided cardiac interventions and their impact on right heart function. Topics include prognostic implications of right ventricular wall tension, novel metrics for RV-PA coupling, clinical effects of severe tricuspid regurgitation, and strategies for transcatheter pulmonary valve replacement in complex right ventricular outflow tract...

Christopher Cook hosts Bernard Prendergast and Nicolas Dumonteil as they discuss their standout moments from the structural track at EuroPCR 2026. Together, they reflect on the evolution of structural interventions showcased throughout the Course, moving beyond TAVI to the growing importance of mitral and tricuspid therapies...

This session offers a comprehensive perspective on valvular heart disease through the lens of lifetime management, highlighting the need for strategic planning across aortic, mitral, and tricuspid interventions, illustrating how treating one valve can influence the progression and management of others. Gain insights into optimal timing...

This EuroPCR 2026 session shifts the focus in tricuspid regurgitation from anatomy alone to the broader context of right heart failure and systemic congestion. It highlights the limitations of purely leaflet-based strategies, particularly in advanced disease and in the presence of severe right ventricular dysfunction.

The discussion...

This session offers comprehensive updates on transcatheter edge-to-edge repair (TEER) for tricuspid valve disease. It reviews meta-analyses on outcomes in patients with cardiac implantable electronic device leads, long-term trial results, echocardiographic and clinical outcomes, right ventricular mechanics, risk scoring, and the impact of renal function and...